Epiloid Biotechnology

Hey there! We're Epiloid Biotechnology, a biotechnology organization based in Toronto, Canada. We provide specialized services focused on preclinical, functional assessment of neuropharmaceuticals in 3D engineered human brain tissues. If you're seeking insights in how your compounds interact in genetically diverse human brains before moving to clinical trials, our team is ready to help. Check out our website for more information: epiloid.com Follow our page and stay tuned for more content! #biotechnology #pharmaceuticals #neurology #startup #epilepsy #parkinsons #preclinical #organoid

Epiloid is delighted to be among the teams supported by the IGNITE program!

À mesure que le Mois de la Sensibilisation à la Santé Cérébrale touche à sa fin, notre engagement envers la santé cérébrale reste plus fort que jamais. Le CABHI, propulsé par Baycrest, est ravi d'annoncer un financement de 2,6 millions de dollars canadiens pour 23 projets grâce à notre programme Ignite, stimulant l'innovation et l'impact dans ce domaine vital. Le programme Ignite de CABHI soutient les innovateurs canadiens en phase précoce (y compris les chercheurs, le personnel en soins de proximité et les entreprises) afin qu'ils puissent développer, tester et valider leurs solutions pour améliorer la vie des personnes âgées, des personnes vivant avec la démence et de leurs aidants. Les participants au programme Ignite recherchent les conseils et l'expertise de CABHI dans le secteur du vieillissement et de la santé cérébrale pour faire avancer les solutions dans six thématiques d'innovation: 🏠 Vieillissement à domicile 💙 Soutien aux aidants ↗️ Coordination et navigation des soins 🧠 Santé cognitive et mentale 💰 Santé financière et bien-être 👵 Santé cérébrale des femmes + FemTech Félicitations à tous les finalistes, et merci Colleges and Universities | Collèges et Universités et à Public Health Agency of Canada | Agence de la santé publique du Canada pour leur soutien généreux dans l'avancement de l'innovation et dans l'amélioration de la qualité de vie des personnes âgées. Rencontrez les lauréats du financement Ignite 2025 de CABHI dans la vidéo ci-dessous! En savoir plus sur les lauréats du financement Ignite ➡️ https://bit.ly/41PIogB caregiVR | Carleton University| Epiloid Biotechnology | Kelello Health | Neuraura | Queen's University | Re:Pair Genomics Inc. | Galit Kleiner | Royal Roads University |VascuBio Innovation | PrimeHealth (formerly ElderPRIME) | Expertiqa Technologies | Factually Health | blueBell Village | blueBell Connect | Incluzia | Marnie Courage | TruMotion Technologies Ltd. | Elderado | Estate Kit | ConSoul

🥁 Drumroll, please 🥁 We are incredibly excited to announce the newest cohort of BioCreate companies! BioCreate was established by Ontario Genomics through a Government of Canada investment of more than $5.6 million from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). Each highly vetted company in the program gets $150,000, 18 months of business mentorship, access to critical infrastructure and the chance to pitch to potential investors. Since the program started in 2023, BioCreate companies have raised $30 million in funding and earned sales and revenue of $8.8 million which represents strong market validation of the commercial potential of the companies funded.  Now, eight new start-ups have been welcomed into BioCreate by Ontario Genomics. Learn more about our newest cohort: Ardra Inc is a business-to-business biotech company focused on creating sustainable and ethical ingredients that are used in food and cosmetics products.    Materia Bioworks is revolutionizing the way eco-friendly materials are being made by simplifying the process for companies to produce biomaterials like sustainable plastics and packaging.    Material Futures is taking all-natural dyes to a new level by using the power of microbes to engineer colourants for a variety of industries.   Inteligex  is a genomics company hoping to change the way traumatic spinal cord injuries are treated by developing drug and stem cell therapies for patients.   Mediphage is a genomics company that has created trademark DNA technology to improve the quality of key ingredients in genetic medicines.   Epiloid Biotechnology is a biotech company focused on finding effective treatments for neurological conditions through data analysis and personalized medicine.   Noa Therapeutics is a biotech company working to create better treatments for the millions of people struggling with inflammatory illnesses like eczema, ulcerative colitis and inflammatory bowel disease.   ProteinQure is looking to lead the charge in making Ontario a thriving hub of drug development and research, while focusing on breast cancer therapies. Learn more about this cohort and BioCreate here: https://lnkd.in/g9JgU2SV

Exciting opportunity for grad students and postdocs in #RegenerativeMedicine! Applications are now open for the SCN-Mitacs Industry-Based Internship Program 2025-2026. 🎓      Train with top Canadian companies, develop life-saving therapies and technologies, and gain valuable industry and academic experience! 🔬  Partner Companies: Axolotl Biosciences, Epiloid Biotechnology, Feldan Therapeutics ǀ Feldan Thérapeutiques, Mediphage Bioceuticals, Mesintel Therapeutics , Octane Orthobiologics, Telescope Therapeutics, and Virano Therapeutics.    🔗 https://lnkd.in/eDXpgPeZ

Offre passionnante pour les étudiants diplômés et les postdoctorants en #MédecineRégénératrice! Nous acceptons actuellement les demandes liées au Programme de stages industriels RCS-Mitacs 2025-2026. 🎓 Formez-vous au sein d'entreprises canadiennes de premier plan, développez des thérapies et des technologies et obtenez une expérience sur le terrain et universitaire précieuse!🔬 Entreprises partenaires : Axolotl Biosciences, Epiloid Biotechnology, Feldan Therapeutics ǀ Feldan Thérapeutiques, Mediphage Bioceuticals, Mesintel Therapeutics , Octane Orthobiologics, Telescope Therapeutics, et Virano Therapeutics. 🔗 https://lnkd.in/e4mr42a8

🌟 Brain Organoid Panel Hosted by Future4Care! 🌟 A big thank you to Future4Care for organizing an incredible panel on the latest in brain organoid research led by Gabrièle Breda & Alaa Abdellatif🧠 ✨ It was inspiring to see world-leading experts exploring the exciting possibilities that arise from combining innovative tech, ethical frameworks, and collaborative efforts. 🤝🔬 Ethical foresight and public trust are essential for unlocking its transformative potential 🚀 Highlights of key points from the Regulatory Science Panel (October 3rd) where the discussion emphasized best practices for responsible brain organoid development, focusing on patient safety and public trust. 🔬 Pioneering Scientific & Ethical Innovation: Emeline Gougeon (Comité Scientifique Pro Anima): Brain organoids are a groundbreaking advancement, but we must address the ethical challenges they bring. Dr. Yousra Laouarem (Helios Neopharma): Integrating AI with organoids is accelerating drug development and disease prevention. 🚀💊 Prof. Dr. Thomas Hartung(Johns Hopkins, Bloomberg School Of Public Health): “Organoid intelligence” is a frontier of integrating brain organoids and AI, presenting both immense potential and challenges. 🧠💡 Dr. Ewelina Kurtys (FinalSpark): Organoids could drive low-energy biocomputing, transforming drug discovery, though future applications are still unfolding. 🏭 Industry & Research Developments: Dr. Vincent Flacher (GDR Organoïdes): France is leading a national network for responsible organoid research, with collaboration, standards, and ethics at its core. 🇫🇷✨ Dr. Mark Aquilino (Epiloid Biotechnology): AI is advancing organoid research, but we must prioritize data reliability, diversity, and privacy. 🔒📊 👥 Crucial Social & Ethical Considerations: Dr. Vanessa dos Reis Ferreira, PhD MBA (Humanized Solutions): Patient and public involvement is essential for responsible brain organoid development. 🗳️👩🔬 Dr. Hervé Chneiweiss (INSERM Ethics Committee): The EBRIDA project sets ethics guidelines for brain organoid research, emphasizing responsibility and clear regulations. 📜⚖️ Dr. Andrea Lavazza (Centro Universitario Internazionale): It’s critical to address the ethical implications of potential consciousness in brain organoids. 🧠🤔 Prof. Dr. Birutė Mockevičienė (MR University): Social science is vital in navigating patient safety, public attitudes, and engagement in organoid research. 🔍🧪 💡 Exciting Announcement Coming Soon! Stay tuned for a major update ! 🎉 In the meantime, check out my The House of Ethics™ interview with Katja Rausch https://lnkd.in/eQzZqWBt for a sneak peek & clue where I explore the future of organoid intelligence. 😊 #Organoids #AI #Bioethics #Innovation #Healthcare #Research Image Source Credit :Muotri Lab/UC San Diego

Epiloid is thrilled to be partnering with the team at #Neuroene Therapeutics to support collaborative innovation through the #BLUEKNIGHT #QuickFireChallenge with Johnson & Johnson Innovation & BARDA. Our team is committed to applying our human brain organoid models of neurological disease & our machine learning platform to inform and de-risk the development of Neuroene's critically needed therapeutics.